New vaccine support (NVS) for ROTA
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. Rotavirus vaccine protects children against rotavirus disease and the severe and deadly diarrhoea that it causes in children. WHO recommends that rotavirus vaccination be included in all national immunization programmes, and the use of rotavirus vaccines should be part of a comprehensive strategy to control diarrhoeal diseases. Two oral rotavirus vaccines are currently available for routine infant immunisation with GAVI support: a two-dose schedule and the three-dose schedule vaccine.
- Project ID
47122-1720-LBR-13B-X- Activity status
- 2 - Implementation
- Aid type
- B02 - Core contributions to multilateral institutions
- % to Liberia
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
- Extending
- United Nations Childrens Fund
Disbursements by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2017 |
Q4 |
616,116.00 |
616,116.00 |
| 2017 |
Q1 |
-8,096.00 |
-8,096.00 |
| 2016 |
Q4 |
292,370.00 |
292,370.00 |
| 2016 |
Q2 |
293,541.00 |
293,541.00 |
Commitments by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2018 |
Q2 |
607,000.00 |
607,000.00 |
| 2017 |
Q2 |
509,315.00 |
509,315.00 |
| 2016 |
Q1 |
618,000.00 |
618,000.00 |
MTEF projections by fiscal year
| Fiscal year |
Value (USD) |
Liberia Value (USD) |
| 2020 |
378,000.00 |
378,000.00 |
| 2019 |
742,250.00 |
742,250.00 |
| 2018 |
711,500.00 |
711,500.00 |
| 2017 |
656,250.00 |
656,250.00 |
| 2016 |
309,000.00 |
309,000.00 |
| CRS code |
% |
|
Infectious disease control
(12250)
|
100.0
|